Company / EPS (Diluted)
Avidity Biosciences, Inc. EPS (Diluted) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.97
FY2025
5-year range
-$4.97 / -$2.85
FY2021-FY2025
Trend
-72.0%
vs FY2024
Sector context
#175 of 204
Health Care
What the data says
Avidity Biosciences, Inc.'s eps (diluted) of $-4.97 is lower than 86% of companies in the Health Care sector (FY2025). Declined from $-2.91 to $-4.97 over the past 2 years.
Based on SEC 10-K filings.
-4.97 in FY2025.
Declined from $-2.91 to $-4.97 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 204This company -$4.97 Sector average -$0.89
▼
-460.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 72.0% year-over-year.
- Ranks #175 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.97 | -72.0% |
| FY2024 | -$2.89 | +0.7% |
| FY2023 | -$2.91 | +12.9% |
| FY2022 | -$3.34 | -17.2% |
| FY2021 | -$2.85 | -39.0% |
| FY2020 | -$2.05 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026